Approvals/TGA/EXELON PATCH 15 rivastigmine 13.3mg/24 hours transdermal drug delivery system sachet

Approved

STANDARD

EXELON PATCH 15 rivastigmine 13.3mg/24 hours transdermal drug delivery system sachet

Approval Id: d6cddf0536f804a8
Product Name: EXELON PATCH 15 rivastigmine 13.3mg/24 hours transdermal drug delivery system sachet
Artg Id: 222604
Artg Name: EXELON PATCH 15 rivastigmine 13.3mg/24 hours transdermal drug delivery system sachet
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2015-04-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-03122-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-03173-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

d6cddf0536f804a8

Type

Standard